Clinical Hepatitis A Vaccine

Hepatitis A susceptible individuals above the age of 18 months. [Function and use] The product can induce immunity against hepatitis A virus in recipients following immunization. It is used to prevent hepatitis A. [Description] The freeze-dried hepatitis A vaccine is a preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest and extraction of the virus, the virus suspension is lyophilized after adding an appropriate stabilizer to make the vaccine. It looks like a milky-white crisp cake and it turns into a clear liquid after reconstitution. Active constituent: live attenuated Hepatitis A virus. Subsidiary materials: All the components of subsidiary materials approved shall be listed. Diluent: sterile water for injection. [Specifications] 1.0 ml of reconstituted vaccine per container. 1.0 ml per single human dose containing not less than 6.50lg CCID50 of live hepatitis A virus. [Feature]  Advantages:   1.Accordance with the trend of biomedicine.                2. Convenient for storage and transportation.                3. The improvement of the stability of the vaccine,30-months of self life.                4. The extension of the validation.